newsJuly 7, 2026·AI News Daily

Insilico Medicine advances AI drug for IPF to Phase III trials

Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients […] The post Insilico Medicine advances AI drug for IPF to Phase III trials appeared first on AI News.

Key Takeaways

•Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF)
•This story was reported by AI News Daily, covering developments in the news space.
•AI advancements continue to reshape industries — read the full article on AI News Daily for complete coverage.

📖 Continue reading the full article:

Read Full Article on AI News Daily →

Share this article

X Facebook Reddit ☕ Support

TechCrunch AI

Anthropic’s Opus 4.6 is a smut-machine

Anthropic forbids its Claude models from generating sexually explicit content. But a series of tests conducted by TechCrunch found that it didn't take much to get past the restriction.

TechCrunch AI

Nvidia partners with data center developer Cloverleaf

Nvidia continues to pour money into data center development — just as AI data centers bring lots of money into Nvidia.

The Verge AI

Over 1 million people have clicked LinkedIn’s AI slop button

LinkedIn actually announced a "Seems like AI slop" button on July 30th, and the company says that a lot of people have already used it. According to a Thursday post from chief product officer Hari Srinivasan, "over a million people" have clicked on the button, which is accessible from the three dots

TechCrunch AI

Nvidia just showed that the harness, not the AI model, is now the real hero

Nvidia research shows that AI agents can perform well, and not go off the deep end, through fine-tuning, even if the AI model isn't that great at the task.

Discussion

Loading articles...

Insilico Medicine advances AI drug for IPF to Phase III trials

Key Takeaways

Related Articles

Anthropic’s Opus 4.6 is a smut-machine

Nvidia partners with data center developer Cloverleaf

Over 1 million people have clicked LinkedIn’s AI slop button

Nvidia just showed that the harness, not the AI model, is now the real hero

Discussion

Insilico Medicine advances AI drug for IPF to Phase III trials

Key Takeaways

Related Articles

Anthropic’s Opus 4.6 is a smut-machine

Nvidia partners with data center developer Cloverleaf

Over 1 million people have clicked LinkedIn’s AI slop button

Nvidia just showed that the harness, not the AI model, is now the real hero

Discussion

Related Articles

TechCrunch AI
Anthropic’s Opus 4.6 is a smut-machine
Anthropic forbids its Claude models from generating sexually explicit content. But a series of tests conducted by TechCrunch found that it didn't take much to get past the restriction.

TechCrunch AI
Nvidia partners with data center developer Cloverleaf
Nvidia continues to pour money into data center development — just as AI data centers bring lots of money into Nvidia.

The Verge AI
Over 1 million people have clicked LinkedIn’s AI slop button
LinkedIn actually announced a "Seems like AI slop" button on July 30th, and the company says that a lot of people have already used it. According to a Thursday post from chief product officer Hari Srinivasan, "over a million people" have clicked on the button, which is accessible from the three dots

TechCrunch AI
Nvidia just showed that the harness, not the AI model, is now the real hero
Nvidia research shows that AI agents can perform well, and not go off the deep end, through fine-tuning, even if the AI model isn't that great at the task.